Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Scribe Therapeutics Inc. (SCTX) had Normalized Income after Taxes of $51.17M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$51.17M |
|
$-21.81M |
|
-- |
|
$51.17M |
|
-- |
|
$51.17M |
|
-- |
|
$51.17M |
|
$51.17M |
|
$51.17M |
|
$-21.81M |
|
$-21.81M |
|
|
Normalized Income after Taxes |
$51.17M |
$51.17M |
|
$51.17M |
|
2.43M |
|
2.43M |
|
$-8.98 |
|
$-8.98 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
-42.62% |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|